SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001144204-18-007983
Filing Date
2018-02-13
Accepted
2018-02-13 16:34:39
Documents
1
Effectiveness Date
2018-02-13

Document Format Files

Seq Description Document Type Size
1 15-12G tv485911_1512g.htm 15-12G 10902
  Complete submission text file 0001144204-18-007983.txt   12219
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 000-12957 | Film No.: 18603970
SIC: 2836 Biological Products, (No Diagnostic Substances)